In support of its clinical relevance, analysis of publicly available datasets via GEPIA revealed that CD26 (DPP4) expression is significantly upregulated in tumor tissues compared to normal tissues in both colon and rectum adenocarcinomas. Here, DPP4 is linked to digestive system cancer.